BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2673460)

  • 21. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy.
    Baro J; Richard C; Sierra J; García-Conde J; García Laraña J; Rocha E; Solano C; Caballero D; Carrera D; León A
    Bone Marrow Transplant; 1992 Jul; 10(1):33-8. PubMed ID: 1515876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
    Fontelonga A; Kelly AJ; MacKintosh FR; Hall S; Monroe P; Wilson GS; Shaft D; Ruthven A; Ascensao JL
    Bone Marrow Transplant; 1997 May; 19(10):983-8. PubMed ID: 9169642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experience.
    Deliliers GL; Annaloro C; Oriani A; Della Volpe A; Boschetti C; Cortelezzi A; Maiolo AT
    Ann Ital Med Int; 1998; 13(3):146-51. PubMed ID: 9859570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
    Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia.
    Straus DJ; Wong GY; Liu J; Oppenberg J; Filippa DA; Gold JW; Offit K; Clarkson BD
    Am J Med; 1991 Mar; 90(3):328-37. PubMed ID: 2003515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma.
    Moreau P; Méchinaud F; Mahé B; Le Tortorec S; Rapp MJ; Maisonneuve H; Harousseau JL; Milpied N
    Bone Marrow Transplant; 1996 Sep; 18(3):665-7. PubMed ID: 8879639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Total body irradiation etoposide followed by autologous hematopoietic stem cell transplantion for non-Hodgkin's lymphoma].
    Shi Y; Lei Y; Zhou S
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):658-61. PubMed ID: 11038787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
    Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin's lymphoma.
    Caracciolo D; Gavarotti P; Aglietta M; Bondesan P; Falda M; Gallo E; Locatelli F; Novarino A; Paolino F; Sanavio F
    Bone Marrow Transplant; 1993 Dec; 12(6):621-5. PubMed ID: 7907906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow.
    Phillips GL; Herzig RH; Lazarus HM; Fay JW; Wolff SN; Mill WB; Lin H; Thomas PR; Glasgow GP; Shina DC
    N Engl J Med; 1984 Jun; 310(24):1557-61. PubMed ID: 6374452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphoblastic non-Hodgkin's lymphoma: estimation of the survival of patients with the disseminated form of the disease (stages III and IV) treated by the LSA2-L2 protocol].
    Pisón Garcés J; Buñuel Alvarez JC; Domínguez Fenollé MP; Castillo Laita JA; Cenarro Guerrero T; Monreal Gálvez MJ; Arana Navarro T; Hernández Gayá A
    An Esp Pediatr; 1991 Dec; 35(6):381-4. PubMed ID: 1793185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission.
    Milpied N; Ifrah N; Kuentz M; Maraninchi D; Colombat P; Blaise D; Harousseau JL
    Br J Haematol; 1989 Sep; 73(1):82-7. PubMed ID: 2803982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
    Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma.
    Brown JR; Gaudet G; Friedberg JW; Neuberg D; Mauch P; Kutok JL; Takvorian T; Fisher DC; Gribben JG; Kim H; Nadler LM; Freedman AS
    Leuk Lymphoma; 2004 Feb; 45(2):315-20. PubMed ID: 15101717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-onset renal dysfunction in a patient with non-Hodgkin's lymphoma following an autologous bone marrow transplantation.
    Tamura H; Mitarai T; Niimi Y; Kato H; Matsumura O; Isoda K
    Nihon Jinzo Gakkai Shi; 1995 Aug; 37(8):474-80. PubMed ID: 7563957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment.
    Hurd DD; LeBien TW; Lasky LC; Haake RJ; Ramsay NK; Kim TH; Levine EG; McGlave PB; Bloomfield CD; Peterson BA
    Am J Med; 1988 Dec; 85(6):829-34. PubMed ID: 3057901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.